Journey Advisory Group’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.24M Buy
+65,347
New +$6.27M 0.48% 57
2025
Q4
Sell
-1,631
Closed -$201K 265
2025
Q3
$201K Sell
1,631
-360
-18% -$44.7K 0.01% 264
2025
Q2
$239K Buy
1,991
+360
+22% +$48K 0.02% 263
2025
Q1
$240K Sell
1,631
-10
-0.6% -$1.53K 0.02% 258
2024
Q4
$224K Hold
1,641
0.03% 214
2024
Q3
$224K Hold
1,641
0.03% 214
2024
Q2
$224K Sell
1,641
-100
-6% -$13.9K 0.03% 214
2024
Q1
$266K Buy
1,741
+3
+0.2% +$448 0.03% 207
2023
Q4
$248K Hold
1,738
0.03% 195
2023
Q3
$228K Buy
1,738
+100
+6% +$15.2K 0.03% 199
2023
Q2
$260K Hold
1,638
0.04% 195
2023
Q1
$259K Sell
1,638
-231
-12% -$34.6K 0.04% 203
2022
Q4
$262K Sell
1,869
-76
-4% -$10.8K 0.07% 196
2022
Q3
$250K Buy
+1,945
New +$281K 0.06% 203
2021
Q2
Sell
-8,758
Closed -$1.69M 202
2021
Q1
$1.69M Buy
8,758
+209
+2% +$40.2K 0.59% 48
2020
Q4
$1.73M Buy
+8,549
New +$1.77M 0.65% 43

Other funds holding CLX

Journey Advisory Group's CLX Position: Q2 2026 in Review

Journey Advisory Group opened a new position in Clorox (CLX) in Q2 2026: 65,347 shares worth $6.24M. The stake represents 0.48% of the portfolio and ranks #57 among its holdings. This is a return to the name: Journey Advisory Group previously reported a position in CLX as recently as Q3 2025.

Journey Advisory Group first reported a position in CLX in Q4 2020 and has held it in 16 quarters since. 694 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Journey Advisory Group held 65,347 shares of Clorox worth $6.24M as of Q2 2026.
  • Clorox was a new Journey Advisory Group position in Q2 2026.
  • Clorox made up 0.48% of Journey Advisory Group's portfolio in Q2 2026, its #57 holding.
  • Journey Advisory Group first reported a position in Clorox in Q4 2020 and has held it in 16 quarters since.
  • 694 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Journey Advisory Group's 13F filing for Q2 2026, filed 4 Aug 2026.